Please use this identifier to cite or link to this item:
doi:10.22028/D291-42509
Title: | Functionalized hydrogels as smart gene delivery systems to treat musculoskeletal disorders |
Author(s): | Enayati, Mohammadsaeid Liu, Wei Madry, Henning Neisiany, Rasoul Esmaeely Cucchiarini, Magali |
Language: | English |
Title: | Advances in Colloid and Interface Science |
Volume: | 331 |
Publisher/Platform: | Elsevier |
Year of Publication: | 2024 |
Free key words: | Injectable hydrogels Nanocomposite hydrogels Self-healing hydrogels Gene therapy Musculoskeletal disorders |
DDC notations: | 610 Medicine and health |
Publikation type: | Journal Article |
Abstract: | Despite critical advances in regenerative medicine, the generation of definitive, reliable treatments for musculoskeletal diseases remains challenging. Gene therapy based on the delivery of therapeutic genetic sequences has strong value to offer effective, durable options to decisively manage such disorders. Furthermore, scaffoldmediated gene therapy provides powerful alternatives to overcome hurdles associated with classical gene therapy, allowing for the spatiotemporal delivery of candidate genes to sites of injury. Among the many scaffolds for musculoskeletal research, hydrogels raised increasing attention in addition to other potent systems (solid, hybrid scaffolds) due to their versatility and competence as drug and cell carriers in tissue engineering and wound dressing. Attractive functionalities of hydrogels for musculoskeletal therapy include their injectability, stimuli-responsiveness, self-healing, and nanocomposition that may further allow to upgrade of them as “intelligently” efficient and mechanically strong platforms, rather than as just inert vehicles. Such functionalized hydrogels may also be tuned to successfully transfer therapeutic genes in a minimally invasive manner in order to protect their cargos and allow for their long-term effects. In light of such features, this review focuses on functionalized hydrogels and demonstrates their competence for the treatment of musculoskeletal disorders using gene therapy procedures, from gene therapy principles to hydrogel functionalization methods and applications of hydrogel-mediated gene therapy for musculoskeletal disorders, while remaining challenges are being discussed in the perspective of translation in patients. Statement of significance: Despite advances in regenerative medicine, the generation of definitive, reliable treatments for musculoskeletal diseases remains challenging. Gene therapy has strong value in offering effective, durable options to decisively manage such disorders. Scaffold-mediated gene therapy provides powerful alternatives to overcome hurdles associated with classical gene therapy. Among many scaffolds for musculoskeletal research, hydrogels raised increasing attention. Functionalities including injectability, stimuli-responsiveness, and self-healing, tune them as “intelligently” efficient and mechanically strong platforms, rather than as just inert vehicles. This review introduces functionalized hydrogels for musculoskeletal disorder treatment using gene therapy procedures, from gene therapy principles to functionalized hydrogels and applications of hydrogelmediated gene therapy for musculoskeletal disorders, while remaining challenges are discussed from the perspective of translation in patients. |
DOI of the first publication: | 10.1016/j.cis.2024.103232 |
URL of the first publication: | https://doi.org/10.1016/j.cis.2024.103232 |
Link to this record: | urn:nbn:de:bsz:291--ds-425095 hdl:20.500.11880/38144 http://dx.doi.org/10.22028/D291-42509 |
ISSN: | 0001-8686 |
Date of registration: | 1-Aug-2024 |
Faculty: | M - Medizinische Fakultät |
Department: | M - Orthopädie |
Professorship: | M - Prof. Dr. Henning Madry |
Collections: | SciDok - Der Wissenschaftsserver der Universität des Saarlandes |
Files for this record:
File | Description | Size | Format | |
---|---|---|---|---|
1-s2.0-S0001868624001556-main.pdf | 9,55 MB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License